US equities
|
SPCX
$168.15
▲+5.78%
NVDA
$237.17
▲+1.38%
MU
$1,065.45
▼-0.88%
TSLA
$378.54
▲+2.15%
MSFT
$526.00
▲+1.64%
INTC
$116.84
▼-2.09%
SNDK
$1,719.73
▼-0.02%
META
$745.71
▲+2.42%
SPCX
$168.15
▲+5.78%
NVDA
$237.17
▲+1.38%
MU
$1,065.45
▼-0.88%
TSLA
$378.54
▲+2.15%
MSFT
$526.00
▲+1.64%
INTC
$116.84
▼-2.09%
SNDK
$1,719.73
▼-0.02%
META
$745.71
▲+2.42%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Compass Therapeutics, Inc.
Compass Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 07, 2022
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference
November 22, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 12, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Therapeutics Announces Pricing of Approximately $125 Million Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
November 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Therapeutics Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
November 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Reports the Advancement of CTX-009, a Bispecific Antibody, to Phase 2a Development in Patients with Biliary Tract Cancers (BTC), and the Clearance of a Key Clinical Hurdle
November 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 08, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Therapeutics and ABL Bio Announce Presentation of CTX-009 Clinical Data as a Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 01, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Therapeutics to Present at the Citi 16th Annual Biopharma Virtual Conference
August 13, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
Compass Therapeutics, Inc. to Acquire TRIGR Therapeutics, Inc.
May 13, 2021
From
Compass Therapeutics, Inc.
Via
Business Wire
Tickers
CMPX
